Gwan G. Song

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 277 publications

Association of neutrophil-to-lymphocyte ratio with disease activity in systemic lupus erythematosus: A meta-analysis.

Association of neutrophil-to-lymphocyte ratio with disease activity in systemic lupus erythematosus: A meta-analysis.

Journal: Lupus

Published: August 24, 2026

Long-term Safety and Efficacy of Anifrolumab in Systemic Lupus Erythematosus: A Meta-Analysis of Randomized Controlled Trials, Extension Studies, and Real-World Cohorts.

Long-term Safety and Efficacy of Anifrolumab in Systemic Lupus Erythematosus: A Meta-Analysis of Randomized Controlled Trials, Extension Studies, and Real-World Cohorts.

Journal: Pharmacology

Published: May 08, 2026

Increased risk of atrial fibrillation in young adults with gout: a nationwide cohort study.

Increased risk of atrial fibrillation in young adults with gout: a nationwide cohort study.

Journal: Frontiers in cardiovascular medicine

Published: April 22, 2026

Risk of disease flare and clinical reversibility following discontinuation versus dose reduction of biological DMARDs in Rheumatoid arthritis: A systematic review and meta-analysis.

Risk of disease flare and clinical reversibility following discontinuation versus dose reduction of biological DMARDs in Rheumatoid arthritis: A systematic review and meta-analysis.

Journal: Seminars in arthritis and rheumatism

Published: March 22, 2026

Comparative Efficacy and Safety of Telitacicept vs. Belimumab in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.

Comparative Efficacy and Safety of Telitacicept vs. Belimumab in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.

Journal: Pharmacology

Published: March 02, 2026

Efficacy and Safety of Janus Kinase Inhibitors in Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Efficacy and Safety of Janus Kinase Inhibitors in Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: January 23, 2026

Superior drug retention of selective JAK1 inhibitors compared to pan-JAK inhibitors in rheumatoid arthritis: A meta-analysis of real-world evidence.

Superior drug retention of selective JAK1 inhibitors compared to pan-JAK inhibitors in rheumatoid arthritis: A meta-analysis of real-world evidence.

Journal: Seminars in arthritis and rheumatism

Published: January 20, 2026

Tocilizumab Biosimilars versus Reference Tocilizumab in Rheumatoid Arthritis: A Meta-Analysis of Pharmacokinetic Biosimilarity, Efficacy, Safety, and Immunogenicity.

Tocilizumab Biosimilars versus Reference Tocilizumab in Rheumatoid Arthritis: A Meta-Analysis of Pharmacokinetic Biosimilarity, Efficacy, Safety, and Immunogenicity.

Journal: Pharmacology

Published: November 19, 2025

Association of folylpolyglutamate synthase polymorphisms with methotrexate response and toxicity in rheumatoid arthritis: a meta-analysis.

Association of folylpolyglutamate synthase polymorphisms with methotrexate response and toxicity in rheumatoid arthritis: a meta-analysis.

Journal: The pharmacogenomics journal

Published: November 12, 2025

Efficacy and Safety of Avacopan in ANCA-Associated Vasculitis: A Meta-Analysis of Randomized Controlled Trials.

Efficacy and Safety of Avacopan in ANCA-Associated Vasculitis: A Meta-Analysis of Randomized Controlled Trials.

Journal: Pharmacology

Published: October 22, 2025

Association between miRNA polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis.

Association between miRNA polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis.

Journal: Biomarkers in medicine

Published: October 21, 2025

Indirect comparative efficacy and safety of belimumab vs. anifrolumab in systemic lupus erythematosus and lupus nephritis: a meta-analysis of randomized trials.

Indirect comparative efficacy and safety of belimumab vs. anifrolumab in systemic lupus erythematosus and lupus nephritis: a meta-analysis of randomized trials.

Journal: Zeitschrift fur Rheumatologie

Published: September 23, 2025

Showing 1-12 of 277

Last Updated: 09/26/2026